Furthermore, eight patients (73%) had tumors that were PD-L1 positive, two patients (18%) had insufficient tumor to determine baseline PD-L1 expression, and one patient (9%) had no PD-L1 expression (Table 1). Here, CD274 is linked to neoplasm.